TABLE II.
Baseline | Follow-Up | P Value | |
---|---|---|---|
Biochemical | |||
Hemoglobin, g/dL | 13.7±0.3 | 14.0±0.4 | .55 |
Platelets, 109/L | 179±12 | 168±11 | .81 |
BUN, mg/dL | 22±2 | 27±3 | .44 |
Creatinine, mg/dL | 1.2±0.1 | 1.2±0.1 | .74 |
eGFR, mL/min | 82±8 | 77±8 | .35 |
Troponin I, ng/mL | 0.04±0.01 | 0.07±0.02 | .08 |
BNP, pg/mL | 388±92 | 481±102 | .52 |
Albumin, g/dL | 4.1±0.1 | 4.0±0.1 | .33 |
Modified BMI, kg g/m2 dL | 100±4 | 95±4 | .21 |
Echocardiographic | |||
LV ejection fraction, % | 50±3 | 48±6 | .61 |
LV end-diastolic diameter, cm | 4.4±0.1 | 4.5±0.1 | .33 |
Interventricular septal thickness, cm | 1.8±0.1 | 1.6±0.1 | .25 |
LV posterior wall thickness, cm | 1.6±0.1 | 1.5±0.2 | .50 |
LA diameter, cm | 4.6±0.2 | 4.5±0.2 | .80 |
LV mass, g/m2 | 384±37 | 331±65 | .36 |
Abbreviations: BMI, body mass index; BNP, B-type natriuretic peptide; BUN, serum urea nitrogen; eGFR, estimated glomerular filtration rate; LA, left atrial; LV, left ventricular.
Mean±standard error at baseline and follow-up, change, and P value from Kruskal-Wallis test are shown.